Kiyoshi Moriyama

1.8k citations
54 papers · 1.2k indexed · h-index 21

Kiyoshi Moriyama

48 papers receiving 1.2k citations

Peers

Kiyoshi Moriyama
Comparison fields: 5 of 115
  • Molecular Medicine 422
  • Molecular Biology 354
  • Pulmonary and Respiratory Medicine 271
  • Endocrinology 196
  • Immunology 186
Replace Jin‐Yong Jeong with:
Jin‐Yong Jeong South Korea
François Guérin France
Isao Nishi Japan
Ya‐Sung Yang Taiwan
Vassiliki Pitiriga Greece
John Merlino United States
Yizhi Peng China
Ming‐Han Tsai Taiwan
Sophie Vimont France
M. Kalin Sweden
Kiyoshi Moriyama relative to Jin‐Yong Jeong South Korea Jin‐Yong Jeong's profile →
Citations per field
00.5×
Jin‐Yong Jeong · 1×
Citations per year

Countries citing papers authored by Kiyoshi Moriyama

Since Specialization
Citations

This map shows the geographic impact of Kiyoshi Moriyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiyoshi Moriyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiyoshi Moriyama more than expected).

Fields of papers citing papers by Kiyoshi Moriyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kiyoshi Moriyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiyoshi Moriyama. The network helps show where Kiyoshi Moriyama may publish in the future.

Co-authorship network of co-authors of Kiyoshi Moriyama

This figure shows the co-authorship network connecting the top 25 collaborators of Kiyoshi Moriyama. A scholar is included among the top collaborators of Kiyoshi Moriyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kiyoshi Moriyama. Kiyoshi Moriyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 35
3 6
4 0
5 0
6 4
7 24
8 23
9 15
10 3
11 5
12 3
13 29
14 23
15 125
16 41
17 57
18 76
19 46
20 29

About Kiyoshi Moriyama

Kiyoshi Moriyama is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Endocrinology, having authored 54 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (10 papers), Respiratory Support and Mechanisms (7 papers) and Bacterial biofilms and quorum sensing (6 papers). The work is most often cited by research in Molecular Medicine (422 citations), Endocrinology (196 citations) and Applied Microbiology and Biotechnology (75 citations). Kiyoshi Moriyama has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Teiji Sawa, Jeanine P. Wiener-Kronish, Kunihiko Kooguchi, Temitayo Ajayi, Masaru Shimizu, Mao Kinoshita, Junzo Takeda, Hiroshi Morisaki, Akitoshi Ishizaka and Leonard R. Allmond. Their work appears in journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026